Systematic Review
Accepted on 25 Dec 2025
Risk of neutropenia associated with Sacituzumab govitecan: a systematic review combined with the FAERS database and Meta-analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
Type at least 3 characters
571 articles
articles
Original Research
Accepted on 23 Dec 2025
Psychotropic Medication Use and Risks of Kidney Injury and Fall-Related Events : A Propensity Score–Matched Cohort Study
in Pharmacoepidemiology
Frontiers in Pharmacology
- 190 views
Original Research
Accepted on 23 Dec 2025
Association of Medication Regimen Complexity Index with ADRs in HIV/AIDS patients: A Retrospective Cohort Study
in Pharmacoepidemiology
Frontiers in Pharmacology
- 113 views
Original Research
Published on 19 Dec 2025
Hydroxyurea utilization among individuals with sickle cell disease in Tennessee: a pooled analysis of claims data
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1693126
- 681 views
Original Research
Accepted on 17 Dec 2025
Real-World Adverse Event Profile and Signal Characteristics of Bevacizumab in Glioma: A FAERS-Based Disproportionality Analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
Original Research
Accepted on 17 Dec 2025
Beyond the label: real-world gastrointestinal adverse events associated with vedolizumab – A decade of FAERS pharmacovigilance
in Pharmacoepidemiology
Frontiers in Pharmacology
Original Research
Accepted on 15 Dec 2025
Pharmacovigilance Insights: Safety Profiles of Antifungal Agents for Invasive Aspergillosis
in Pharmacoepidemiology
Frontiers in Pharmacology
- 153 views
Original Research
Accepted on 15 Dec 2025
Maternal Influenza Vaccination During Pregnancy and the Risk of Adverse Pregnancy and Birth Outcomes
in Pharmacoepidemiology
Frontiers in Pharmacology
- 107 views
Original Research
Published on 12 Dec 2025
Medication adherence in the elderly population with chronic diseases: a factor analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1699999
- 679 views
Original Research
Accepted on 11 Dec 2025
Medication use in Poland for children and adolescents with Neurodevelopmental disorders: before, during and after the COVID-19 pandemic - a retrospective pharmacoepidemiological study using national reimbursement data
in Pharmacoepidemiology
Frontiers in Pharmacology
- 197 views
Original Research
Accepted on 11 Dec 2025
Drug-Induced Peripheral Nerve Palsy: A Real-World Study Based on FAERS Data from 2004 to the Third Quarter of 2024
in Pharmacoepidemiology
Frontiers in Pharmacology
- 125 views
Original Research
Published on 11 Dec 2025
Disproportionality analysis of safety signals for milnacipran and levomilnacipran: a pharmacovigilance study using the FDA adverse event reporting system
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1719881
- 725 views
Original Research
Published on 11 Dec 2025
Real-world safety of tirofiban: a disproportionality analysis using data from FAERS and WHO-VigiAccess
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1713141
- 853 views
Original Research
Accepted on 05 Dec 2025
Spectrum Mining of Immune Checkpoint Inhibitor-Related Cutaneous Toxicities and Analysis of Associated Factors Based on FAERS
in Pharmacoepidemiology
Frontiers in Pharmacology
- 172 views
Original Research
Published on 02 Dec 2025
Knowledge, attitudes, and practices of pharmacists toward over-the-counter medication use in Iraq: a nationwide cross-sectional study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1669176
- 623 views
Original Research
Accepted on 01 Dec 2025
Voriconazole-Associated Liver Injury: Clinical Risk Factor Identification and Predictive Nomogram Construction
in Pharmacoepidemiology
Frontiers in Pharmacology
- 148 views
Original Research
Accepted on 01 Dec 2025
Atrial Fibrillation Signals with Overactive Bladder Drugs across JADER and FAERS: Disproportionality and Time-to-Onset Analyses
in Pharmacoepidemiology
Frontiers in Pharmacology
- 230 views
Original Research
Accepted on 30 Nov 2025
Comparative Safety Profiles of Spironolactone, Eplerenone, and Finerenone: A Pharmacovigilance Study Based on FAERS Data from 2004 to 2024
in Pharmacoepidemiology
Frontiers in Pharmacology
- 281 views
Original Research
Published on 28 Nov 2025
Real-world pharmacovigilance insights into drug-induced risk of alopecia
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1703423
- 997 views
Original Research
Published on 27 Nov 2025
Disproportionality analysis of taste disorders using the FDA adverse event reporting system and Japanese adverse drug event report databases
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1659746
- 650 views
Original Research
Published on 26 Nov 2025
Severe cutaneous adverse reactions to anti-osteoporosis drugs: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database and a review of published cases
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1707885
- 873 views
Original Research
Published on 25 Nov 2025
Trend analysis and future projections of global burden of opioid use disorder (OUD) from 1990 to 2030
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1669269
- 973 views
Original Research
Published on 24 Nov 2025
Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1700589
- 1,187 views
Original Research
Published on 21 Nov 2025
Comparative safety profile of levofloxacin versus moxifloxacin in first-line tuberculosis therapy: a pharmacovigilance study of the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1713170
- 1,084 views